Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in VANI — Vivani Medical, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to VANI Full portfolio

Position in VANI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$1 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record

Common Shares in VANI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,878 across 417 Biotechnology names. VANI ranks #417 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in VANI

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $0 0
2026-03-31 $1 1
2025-12-31 $1 1
2025-09-30 $1 1
2025-06-30 $1 1
2024-03-31 $412 223
2023-12-31 $223 219
2023-09-30 $212 208
2023-06-30 $314 260
2023-03-31 $249 249
2022-12-31 $491 578
2022-09-30 $900 395